Tower Research Capital (TRC)
IXHL icon

Tower Research Capital (TRC)’s Incannex Healthcare Limited Common Stock IXHL Stock Holding History

Tower Research Capital (TRC)’s Portfolio IXHL Stock Details IXHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-71
Closed -$7.66K – 5853
2024
Q1 		$7.66K Sell
71
-16
-18% -$1.92K ﹤0.01% 4172
2023
Q4 		$12.1K Buy
+87
New +$11.3K ﹤0.01% 4079
2022
Q4 		– Hold
0
– – – 6148
2022
Q3 		– Hold
0
– – – 6277

Other funds holding IXHL

Tidal Investments
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.53% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Old Mission Capital
Old Mission Capital Chicago, Illinois $6.31B AUM 20.8% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tower Research Capital (TRC)'s IXHL Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of Incannex Healthcare Limited Common Stock (IXHL) in Q2 2024, closing a stake of 71 shares — an estimated $7.66K sold.

Tower Research Capital (TRC) first reported a position in IXHL in Q4 2023 and held it in 2 quarters. The position peaked at $12.1K in Q4 2023. 11 funds tracked by Wall St. Rank hold IXHL as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining Incannex Healthcare Limited Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 71 Incannex Healthcare Limited Common Stock shares in Q2 2024, an estimated $7.66K.
  • Tower Research Capital (TRC) first reported a position in Incannex Healthcare Limited Common Stock in Q4 2023 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Incannex Healthcare Limited Common Stock position peaked at $12.1K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held Incannex Healthcare Limited Common Stock as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.